SCHEMBL333837

SCHEMBL333837

O=C(O)C=Cc1ccccn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.60
RAB9A P51151 3/20 0.60
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
ATM Q13315 1/20 0.60
HSP90AA1 P07900 2/20 0.59
HDAC3 O15379 2/20 0.54
HDAC4 P56524 2/20 0.54
HDAC1 Q13547 2/20 0.54
HDAC7 Q8WUI4 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC10 Q969S8 2/20 0.54
HDAC11 Q96DB2 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
HDAC9 Q9UKV0 2/20 0.54
HDAC5 Q9UQL6 2/20 0.54
TNKS O95271 1/20 0.54
HCAR2 Q8TDS4 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29779566 1.00 NPC1 (0.60) NPC1RAB9AMEN1KMT2AATM
SCHEMBL333836 1.00 NPC1 (0.60) NPC1RAB9AMEN1KMT2AATM
Ammonia Solution, Strong SCHEMBL28834704 0.98 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
Hydrochloric Acid SCHEMBL5200839 0.98 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
Hydrochloric Acid SCHEMBL1769092 0.98 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
Pyrrole SCHEMBL28128978 0.89 HSP90AA1 (0.50) NPC1RAB9AMEN1KMT2AATM
SCHEMBL6784945 0.86 NPC1 (0.54) NPC1RAB9AMEN1KMT2AATM
SCHEMBL30317323 0.85 NPC1 (0.62) NPC1RAB9AMEN1KMT2AATM
SCHEMBL11999774 0.85 NPC1 (0.62) NPC1RAB9AMEN1KMT2AATM
SCHEMBL11433821 0.84 HCAR2 (0.71) NPC1RAB9AMEN1KMT2AHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 407 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112574664-B Ultraviolet-resistant wet heat aging transparent PI hardening coating and preparation method thereof 新恒东薄膜材料(常州)有限公司 2023-08-11 CN claimed
CN-115960365-A Biological terminal hydroxyl hyperbranched polyester, hyperbranched UV (ultraviolet) curing resin, and preparation method and application thereof 上海交通大学 2023-04-14 CN claimed
CN-114058199-B UV-cured super-hydrophilic anti-fog coating and preparation method and application thereof 深圳南科新材科技有限公司 2022-11-08 CN claimed
EP-4043202-A1 ELECTROPLATED NON-ALLERGENIC PT-NI ALLOY AND BATH AND GALVANIC CYCLE THEREOF BLUCLAD S.p.A. (IT) 2022-08-17 EP claimed
CN-114058199-A UV-cured super-hydrophilic anti-fog coating and preparation method and application thereof 深圳南科新材科技有限公司 2022-02-18 CN claimed
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US claimed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US claimed
US-10297860-B2 Lithium secondary battery LG CHEM, LTD. (KR) 2019-05-21 US claimed
US-9882239-B2 Composition for gel polymer electrolyte and lithium secondary battery including the same LG CHEM, LTD. (KR) 2018-01-30 US claimed
EP-2431502-B1 CYANIDE-FREE SILVER ELECTROPLATING SOLUTIONS ROHM & HAAS ELECT MAT (US) 2017-05-24 EP claimed
EP-1085095-A1 Synthesis of optically active phenylalanine analogs through microbial transformations NSC Technologies Company, L.L.C. (US) 2001-03-21 EP claimed
US-5995869-A Reduction of skin sensitization in electrotransport drug delivery ALZA CORPORATION (US) 1999-11-30 US claimed
US-5981239-A USING LYASE FROM RHODOTORULA TO INTRODUCE AMMONIA STEREOSPECIFICALLY INTO DOUBLE BOND OF AN ARYLACRYLIC ACID; AMINO ACID FOR USE IN VIRICIDAL PROTEASE INHIBITORS AGAINST HUMAN IMMUNODEFICIENCY VIRUS, INFLUENZA AND OTHERS GREAT LAKES CHEMICAL CORP. (US) 1999-11-09 US claimed
US-5939268-A DIELS-ALDER REACTION PRODUCT OF A DIENE AND A DIENOPHILE; CHEMICAL INTERMEDIATES FOR DRUGS, SOLID PHASE SYNTHESIS THE SCRIPPS RESEARCH INSTITUTE (US) 1999-08-17 US claimed
EP-0917501-A1 METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES Tecle, Berhan (US) 1999-05-26 EP claimed
WO-1997047355-A1 REDUCTION OF SKIN SENSITIZATION IN ELECTROTRANSPORT DRUG DELIVERY ALZA CORPORATION (US) 1997-12-18 WO claimed
WO-1997033713-A1 METHOD FOR ISOLATING ULTRAFINE AND FINE PARTICLES AND RESULTING PARTICLES TECLE BERHAN (US) 1997-09-18 WO claimed
EP-0773953-A1 COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME THE SCRIPPS INSTITUTE (US) 1997-05-21 EP claimed
WO-1996003424-A1 COMBINATORIAL LIBRARIES OF MOLECULES AND METHODS FOR PRODUCING SAME THE SCRIPPS RESEARCH INSTITUTE (US) 1996-02-08 WO claimed
US-4443380-A Organic europlum salt phosphor ASAHI-DOW LIMITED (JP) 1984-04-17 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829466-B2 Stilbene derivative and preparation method thereof STS, F12, GLB1 NPC1 1617/4885RAB9A 3348/4885MEN1 1417/4885
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF STS, F12, STK38L NPC1 1139/4885RAB9A 2916/4885MEN1 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.